These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 22576846)

  • 41. Resistant hypertension revisited: a comparison of two university-based cohorts.
    Garg JP; Elliott WJ; Folker A; Izhar M; Black HR;
    Am J Hypertens; 2005 May; 18(5 Pt 1):619-26. PubMed ID: 15882544
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Understanding racial disparities in treatment intensification for hypertension management.
    Manze M; Rose AJ; Orner MB; Berlowitz DR; Kressin NR
    J Gen Intern Med; 2010 Aug; 25(8):819-25. PubMed ID: 20386998
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antihypertensive medication changes and blood pressure goal achievement in a managed care population.
    Engel-Nitz NM; Darkow T; Lau H
    J Hum Hypertens; 2010 Oct; 24(10):659-68. PubMed ID: 20107489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A specific questionnaire to evaluate therapeutic inertia in hypertensive patients: a pilot study].
    Pretorean T; Claisse G; Delsart P; Caudrelier T; Devos P; Mounier-Vehier C
    J Mal Vasc; 2014 Feb; 39(1):4-13. PubMed ID: 24119421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypertension treatment intensification among stroke survivors with uncontrolled blood pressure.
    Roumie CL; Zillich AJ; Bravata DM; Jaynes HA; Myers LJ; Yoder J; Cheng EM
    Stroke; 2015 Feb; 46(2):465-70. PubMed ID: 25550374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ambulatory hypertensive patients treated by cardiologists in France.
    Blacher J; Peroz-Froz J; Huberman JP; Ferrini M; Jullien G; Guenoun M; Guedj-Meynier D
    Arch Cardiovasc Dis; 2013 Feb; 106(2):86-92. PubMed ID: 23527912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of medication adherence on blood pressure control and risk factors for antihypertensive medication adherence.
    Yue Z; Bin W; Weilin Q; Aifang Y
    J Eval Clin Pract; 2015 Feb; 21(1):166-72. PubMed ID: 25318567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health insurance status and hypertension monitoring and control in the United States.
    Duru OK; Vargas RB; Kermah D; Pan D; Norris KC
    Am J Hypertens; 2007 Apr; 20(4):348-53. PubMed ID: 17386339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antihypertensive medication adherence and blood pressure control among central Alabama veterans.
    Piercefield EW; Howard ME; Robinson MH; Kirk CE; Ragan AP; Reese SD
    J Clin Hypertens (Greenwich); 2017 May; 19(5):543-549. PubMed ID: 27917605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program.
    Magid DJ; Olson KL; Billups SJ; Wagner NM; Lyons EE; Kroner BA
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):157-63. PubMed ID: 23463811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study.
    Xu W; Goldberg SI; Shubina M; Turchin A
    BMJ; 2015 Feb; 350():h158. PubMed ID: 25655523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antihypertensive Adherence Trajectories Among Older Adults in the First Year After Initiation of Therapy.
    Hargrove JL; Pate V; Casteel CH; Golightly YM; Loehr LR; Marshall SW; Stürmer T
    Am J Hypertens; 2017 Oct; 30(10):1015-1023. PubMed ID: 28535297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting blood pressure outcomes using single-item physician-administered measures: a retrospective pooled analysis of observational studies in Belgium.
    Villa L; Sun D; Denhaerynck K; Vancayzeele S; Brié H; Hermans C; Aerts A; Levengood M; MacDonald K; Abraham I
    Br J Gen Pract; 2015 Jan; 65(630):e9-15. PubMed ID: 25548319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
    Grant RW; Singer DE; Meigs JB
    Clin Ther; 2005 Jun; 27(6):773-81. PubMed ID: 16117984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of hypertension in an elderly outpatient population in the Netherlands.
    Tulner LR; Kuper IM; van Campen JP; Koks CH; Mac Gillavry MR; Beijnen JH; Brandjes DP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):204-9. PubMed ID: 19766952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypertension treatment practices and its determinants among ambulatory patients: retrospective cohort study in Ethiopia.
    Berhe DF; Taxis K; Haaijer-Ruskamp FM; Mulugeta A; Mengistu YT; Mol PGM
    BMJ Open; 2017 Aug; 7(8):e015743. PubMed ID: 28775184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patients' confidence in methods of blood pressure assessment and their reported adherence to antihypertensive medications.
    Alvarez P; Zeng J; Tuttle L; Viera AJ
    Blood Press Monit; 2017 Oct; 22(5):259-264. PubMed ID: 28542089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.